Author

A. Foudi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

A. G. Turhan· 3 shared C. Desterke· 3 shared A. Bennaceur Griscelli· 2 shared I. Simanic· 2 shared J. Artus· 2 shared S. Coignard· 2 shared Y. Ijjeh· 2 shared A. Bennaceur-Griscelli· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. G. Turhan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BCR-ABL promotes hematopoietic stem and progenitor cell formation in embryonic stem cells

J. Artus, A. Zenych, I. Simanic, C. Desterke, D. Clay, S. Saim, Y. Ijjeh, L. E. B. de Souza, S. Coignard, A. Bennaceur-Griscelli, A. G. Turhan, A. Foudi

This study shows that BCR-ABL expression in murine ESCs promotes the formation and maintenance of hematopoietic progenitors with a molecular signature similar to wild-type HSCs.

bioRxiv · Feb 3, 2023Cancer Biology

miR-495-3p Sensitizes BCR::ABL1 Expressing Leukemic cells to Tyrosine Kinase Inhibitors by Targeting Multidrug Resistance 1 Gene including in T315I Mutated cells

Y. Rittavee, J. Artus, C. Desterke, I. Simanic, L. Eduardo Botelho de Souza, S. Riccaldi, S. Coignard, Y. Ijjeh, P. Hugues, A. Bennaceur Griscelli, A. G. Turhan, A. Foudi

This study shows miR-495-3p reduces CML cell growth and TKI resistance by targeting MDR1, especially in T315I-mutant cells, and identifies it as a potential therapeutic target.

Experimental Hematology · Feb 1, 2023Peer-reviewedCancer Biology

iPSC-derived Cancer Organoids Recapitulate Genomic and Phenotypic Alterations of c-met-mutated Hereditary Kidney Cancer

J. W. Hwang, C. Desterke, O. Feraud, S. Richard, S. Ferlicot, V. Verkarre, J. J. Patard, J. Loisel-Duwattez, A. Foudi, F. Griscelli, A. Bennaceur Griscelli, A. G. Turhan

The paper generates c-met-mutated iPSC-derived kidney organoids that recapitulate genomic and phenotypic features of PRCC, identifying common genes and validating their expression in both organoids and patient tumors.

bioRxiv · Jan 11, 2019 · PreprintCancer Biology